stockrowPrivia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) Net income
Privia Health Group, Inc.'s net income for fiscal 2025 was $29.7M, up 74.4% from $17.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $38.6M. Over the past ten years it has ranged from −$190.6M (fiscal 2021) to $30.9M (fiscal 2020); the current reading is higher than 89% of that period. Privia Health Group, Inc. ranks 8th of 44 Health Information Services companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $29.7M | 74.41% |
| FY2024 | $17.0M | (18.95%) |
| FY2023 | $21.0M | — |
| FY2022 | −$12.1M | — |
| FY2021 | −$190.6M | — |
| FY2020 | $30.9M | 288.97% |
| FY2019 | $7.9M | — |
| FY2018 | −$3.0M | — |
| FY2017 | $0.00 | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $14.6M | 49.93% |
| Jun 2026 | $9.7M | 162.37% |
| Mar 2026 | $3.7M | (64.95%) |
| Dec 2025 | $10.6M | 7.93% |
| 24 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| DOCS Doximity, Inc. compare | $139.7M |
| WAY Waystar Holding Corp. compare | $135.2M |
| OMCL Omnicell, Inc. compare | $44.7M |
| PRVA Privia Health Group, Inc. | $38.6M |
| GDRX GoodRx Holdings, Inc. compare | $16.2M |
| SDGR Schrodinger, Inc. compare | −$59.3M |
| CERT Certara, Inc. compare | −$64.3M |
| HTFL Heartflow, Inc. compare | −$118.4M |
| TDOC Teladoc Health, Inc. compare | −$154.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on PRVA
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement